BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6456688)

  • 21. New drug evaluations: moxalactam (Moxam, Eli Lilly).
    Polk RE
    Drug Intell Clin Pharm; 1982 Feb; 16(2):104-12. PubMed ID: 6210519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bacteriological and clinical studies of 6059-S in pediatric infections (author's transl)].
    Terashima I; Nakamura A; Okimoto U; Sugaya N; Kurosaki T; Sato T; Iwata Y; Saito N; Uehara S
    Jpn J Antibiot; 1981 May; 34(5):747-56. PubMed ID: 6457173
    [No Abstract]   [Full Text] [Related]  

  • 23. Moxalactam therapy for a wide spectrum of bacterial infections in adults.
    Tofte RW; Rotschafer J; Solliday J; Crossley KB
    Antimicrob Agents Chemother; 1981 May; 19(5):740-4. PubMed ID: 6457555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical evaluation of moxalactam].
    Acar JF
    Sem Hop; 1983 Jun; 59(26):1990-3. PubMed ID: 6310793
    [No Abstract]   [Full Text] [Related]  

  • 25. Moxalactam treatment of serious infections primarily due to Haemophilus influenzae type b in children.
    Kaplan SL; Mason EO; Kvernland SJ; Loiselle EM; Feigin RD
    Pediatrics; 1983 Feb; 71(2):187-91. PubMed ID: 6218472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moxalactam therapy of bacterial meningitis in adults.
    Uwaydah M; Tannir N; Kantarjian H; Osseiran M; Bal'a F
    Antimicrob Agents Chemother; 1983 Feb; 23(2):289-92. PubMed ID: 6220673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enterococcal infections in patients treated with moxalactam.
    Moellering RC
    Rev Infect Dis; 1982; 4 Suppl():S708-11. PubMed ID: 6218588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
    Mueller O; Fabricius K; Krueger E; Rueckert U
    Rev Infect Dis; 1982; 4 Suppl():S688-91. PubMed ID: 6218584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Moxalactam in complications of abdominal surgery].
    Dupeyron JP; Peter JD; Rigolot JC
    Sem Hop; 1983 Jun; 59(26):1985-9. PubMed ID: 6310792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity, efficacy, and pharmacology of moxalactam, a new beta-lactam antibiotic.
    Snepar R; Poporad G; Romano J; Levison ME
    Antimicrob Agents Chemother; 1981 Nov; 20(5):642-7. PubMed ID: 6459763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Moxalactam in the treatment of intraabdominal sepsis and other surgical infections.
    Busuttil RW; McGrattan MA; Winston DJ
    Rev Infect Dis; 1982; 4 Suppl():S676-82. PubMed ID: 6218582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
    Stone HH; Kolb L; Geheber CE
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):351-5. PubMed ID: 6221242
    [No Abstract]   [Full Text] [Related]  

  • 33. Moxalactam in serious infections: clinical, bacteriologic, and pharmacokinetic studies.
    Giamarellou H; Tsagarakis J; Daikos GK
    Rev Infect Dis; 1982; 4 Suppl():S629-38. PubMed ID: 6218576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Moxalactam - a beta-lactam antibiotic in the monotherapy of severe infections in surgery. Clinico-bacteriological study of 35 patients].
    Gonzenbach HR; Sonnabend W
    Schweiz Med Wochenschr; 1981 Aug; 111(31-32):1169-83. PubMed ID: 6456543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Moxalactam therapy of infections caused by cephalothin-resistant bacteria: influence of serum inhibitory activity on clinical response and acquisition of antibiotic resistance during therapy.
    Platt R; Ehrlich SL; Afarian J; O'Brien TF; Pennington JE; Kass EH
    Antimicrob Agents Chemother; 1981 Sep; 20(3):351-5. PubMed ID: 6458233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moxalactam in pediatrics.
    Barson WJ; Nahata MC
    Drug Intell Clin Pharm; 1982 Feb; 16(2):113-4. PubMed ID: 6210520
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical studies of 6059-S in the field of pediatrics (author's transl)].
    Minamitani M; Hachimori K; Tomori N
    Jpn J Antibiot; 1981 Apr; 34(4):608-17. PubMed ID: 6457169
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical studies on 6059-S in pediatric field (author's transl)].
    Nagata K; Fujita M; Haneda S; Aoyama R; Izumi Y
    Jpn J Antibiot; 1981 Apr; 34(4):558-61. PubMed ID: 6457164
    [No Abstract]   [Full Text] [Related]  

  • 39. Moxalactam for treatment of nosocomial infections.
    Winston DJ; Kurtz TO; Young LS; Busuttil RW
    Rev Infect Dis; 1982; 4 Suppl():S650-S655. PubMed ID: 6218578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moxalactam treatment of anaerobic infections in cancer patients.
    Lagast H; Meunier-Carpentier F; Klastersky J
    Antimicrob Agents Chemother; 1982 Oct; 22(4):604-10. PubMed ID: 6217784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.